(S,R,S)-AHPC-PEG1-azide is a high-quality E3 Ligase Ligand-Linker Conjugate, specifically designed for use in PROTAC (Proteolysis Targeting Chimera) drug discovery and targeted protein degradation research. This compound integrates the AHPC (hydroxyproline-based) ligand, known for its selective recruitment of the von Hippel-Lindau (VHL) E3 ubiquitin ligase, with a PEG1 (polyethylene glycol) linker and an azide functional group for versatile conjugation. As a bifunctional building block, (S,R,S)-AHPC-PEG1-azide enables the efficient synthesis of PROTAC molecules by providing a modular handle for coupling a variety of target protein ligands through bioorthogonal click chemistry. By facilitating the recruitment of the E3 ligase to target proteins, this conjugate enables ubiquitination and subsequent proteasomal degradation of disease-relevant proteins, paving the way for innovative therapies in oncology, neurodegeneration, and beyond. Its high purity and well-defined structure make it an excellent choice for researchers aiming to develop next-generation protein degraders and advance the field of targeted protein degradation.
Structure of 2101200-09-1
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 100 mg | $499 | In stock | |
| 1 g | $2690 | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-PEG1-azide is a specialized E3 ligase ligand-linker conjugate designed for use in targeted protein degradation applications. By incorporating AHPC (hydroxyproline-based ligand) for recruiting the von Hippel-Lindau (VHL) E3 ubiquitin ligase, this molecule is optimized for the construction of PROTACs (Proteolysis Targeting Chimeras). The PEG1 (polyethylene glycol) spacer and terminal azide group enable straightforward conjugation to diverse protein-targeting ligands via click chemistry, facilitating the development of custom PROTAC molecules.
Mechanism
The mechanism of (S,R,S)-AHPC-PEG1-azide centers on its ability to recruit the VHL E3 ubiquitin ligase by mimicking the natural substrate hydroxyproline residue. Upon conjugation to a protein-binding ligand (such as a small molecule or peptide), (S,R,S)-AHPC-PEG1-azide forms a bifunctional PROTAC molecule. This PROTAC bridges the targeted protein of interest with VHL, inducing ubiquitination and subsequent degradation of the target protein by the 26S proteasome. The PEG1 linker provides optimal spatial orientation, while the azide group allows rapid, high-yielding conjugation through azide-alkyne click chemistry.
Applications
(S,R,S)-AHPC-PEG1-azide is an essential research tool for generating custom small-molecule degraders in drug discovery and chemical biology. Its primary applications include:
(1) Construction of novel PROTACs targeting a wide variety of disease-related proteins,
(2) Functional evaluation of protein knockdown effects in cell-based assays and animal models
(3) The development of next-generation degraders with improved selectivity, bioavailability, and pharmacokinetic profiles.
This reagent is invaluable for academic and pharmaceutical researchers seeking to expand targeted protein degradation strategies.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.